Health Condition 1: M489- Spondylopathy, unspecified
Conditions
Interventions
Intervention1: Dexmedetomidine for sedation in awake fibreoptic nasotracheal intubation: Dexmedetomidine loading dose of 0.4mcg/kg at a concentration of 2mcg/cc over 10minutes followed by a continuous
Sponsors
MS Ramaiah Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18-75 year olds 2. ASA I-III 3. Maxillofacial trauma patients 4. Patients with oral carcinoma 5. Trismus
Exclusion criteria
Exclusion criteria: 1. Nasal trauma 2. Pregnant and lactating women 3. Heart Rate less than 50 bpm 4. AV block on ECG 5. History of angina 6. Liver cirrhosis 7. History of long time opioid use or use within last 14days 8. Allergy to drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| first attempt success rate and quality of intubationTimepoint: Time interval between sedation and confirmation of ventilation with end tidal carbon dioxide being displayed on the monitor, in the first attempt, approximately 10minutes after the loading dose is completed | — |
Secondary
| Measure | Time frame |
|---|---|
| time required to achieve RSS of 2Timepoint: interval between start of sedation to when patient is cooperative, oriented & tranquil, approximately 5minutes after the loading dose is completed;Total duration for successful tracheal intubationTimepoint: sum of all attempts taken to successfully intubate the patient endotracheally, approximately 15minutes after the loading dose is completed | — |
Countries
India
Contacts
Public ContactDr Geetha C R
M S Ramaiah Medical College
Outcome results
None listed